Evidence map›Paper›PMID 41940392›Full record

ArticlePeerJ2026

Role of dendritic cells and B cells in the skin of imiquimod (IMQ)-induced psoriasis-like mouse model.

Aina Akmal Mohd Noor, Lidawani Lambuk, Farizan Ahmad, Maryam Azlan, Norhanani Mohd Redzwan

Abstract read
In one paragraph

Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aina Akmal Mohd NoorDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Lidawani LambukDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Farizan AhmadDepartment of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Maryam AzlanSchool of Health Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Norhanani Mohd RedzwanDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Psoriasis is a chronic inflammatory skin disease traditionally characterized by T cell-mediated immune responses. However, dendritic cells (DCs) and B cells also contribute to immune regulation in psoriasis. Their role in disease progression remains underexplored. Methods: This study utilized an imiquimod (IMQ)-induced psoriasis-like mouse model to investigate DC and B cell dynamics at different stages of disease progression (day 3, day 5 and day 7). Skin lesions were evaluated using the Psoriasis Area and Severity Index (PASI) and histological analysis. Flow cytometry was performed to assess the expression of CD11c Results: IMQ application induced progressive skin thickening, erythema and scaling, with PASI scores significantly increased at day 7 compared to controls ( Conclusion: Early DC activation corresponded with the initiation phase of inflammation, while the later expansion of B cells appeared to coincide with sustained inflammatory activity and disease progression. The coordinated presence of DCs and B cells in the skin microenvironment may influence disease severity and pathogenesis, which could provide fundamental insights for future investigations into potential therapeutic strategies.

Indexed as

B-LymphocytesDendritic CellsPsoriasisSkinAminoquinolinesAnimalsDisease Models, AnimalFemaleImiquimodMiceAminoquinolinesImiquimodB cellDendritic cellImiquimodMouse modelPsoriasisSkin

Identifiers

PMID41940392
PMCPMC13045838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.